NewsRoom Articles - Page 91 of 112 - CanadianCannabisWire

MondayAug 27, 2018 11:01 am

The Flowr Corporation is “One to Watch”

High quality, non-irradiated “whole flower” cannabis to be produced at scale with focus on optimizing crop yields and quality to maximize profitability and return on investment Co-founder Tom Flow is a world renown cultivation expert and co-founder of MedReleaf (acquired by Aurora Cannabis for C$3.2 billion) General shortage of high-quality cannabis flower in Canada expected over near term – Flowr’s 60,000 kg targeted capacity will help fill this gap while commanding premium prices Cultivation facilities designed to support ultra-high yields with each room targeting six harvests and an industry leading ~450 g/SF/year once optimized resulting in relatively low cost of…

ThursdayAug 23, 2018 10:04 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug Delivery Platform Takes Dosage from Zero to 203 in 15 Minutes

DehydraTECH™ methodology offers safer alternative to smoking Possible nicotine delivery platform for Big Tobacco Several licensing agreements for technology already signed Formula One racing is not the only place to find speed. The drug delivery platform DehydraTECH™, developed by Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), has proven that it’s just as fast. In recent in vivo tests, the technology delivered 203 nanograms per milliliter (ng/mL) of nicotine in 15 minutes, 70 percent more than the control. Such rapidity may rival smoking; particularly as new research (http://cnw.fm/gi1Aw) suggests that “nicotine takes much longer than previously thought to reach peak levels in…

WednesdayAug 22, 2018 12:20 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Acquires Worldwide License for Herbal Sleep Aids

Millions worldwide affected by sleep disorders Sleep disorder market set to exceed $50 billion by 2020 New marketing initiative kicks off with engagement of IR firm Updated Crystal Equity Research report now available Counting sheep may soon be a thing of the past, for PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) has been awarded a worldwide license to manufacture, distribute and market three Health Canada-approved sleep aids (http://cnw.fm/K2s5q). This milestone could not have come at a better time. Sleeping disorders affect around 40 percent of adults in Canada (approximately 15 million), according to a study conducted at the Université…

WednesdayAug 22, 2018 11:40 am

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Acquires Leading European CBD Company HemPoland

Acquisition includes 100 percent of issued and outstanding shares of privately-held HemPoland in an immediate accretive cash and share transaction worth $15.5 million with an additional $10.3 million committed to R&D, global expansion Agreement opens European gateway with distribution channels to over 750 million people and sales in over 700 locations across 13 countries In 2017, HemPoland produced more than 32,000 kg of organic dried flower and 310 kg of organic CBD oils from over 1,250 acres of cultivation Deal accelerates TGOD’s strategic plan to become the world’s largest organic cannabis brand In a move that dramatically accelerates its strategic…

TuesdayAug 21, 2018 1:56 pm

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Funds Cannabis Companies with Innovative Royalty Financing Model

FinCanna advances $2.25 million to Refined Resin Technologies and ezGreen Compliance California sales account for one-third of U.S. cannabis market California market projected to grow by CAGR of 23 percent to $6.5 billion by 2020 California is now home to the largest legal cannabis market in the world. A pioneer of medical marijuana, which it legalized in 1998, the state has gone a step further by legalizing adult use of marijuana as of January 1, 2018. As a result, sales, already accounting for one-third of legal cannabis sales revenues in the U.S., are projected to reach $4.3 billion in 2018…

MondayAug 20, 2018 2:14 pm

The Green Organic Dutchman Ltd. (TSX: TGOD) (OTC: TGODF) Prepares to Spin Off Acquisitions Entity with Opportunity for Shareholders

The Green Organic Dutchman is building a cannabis industry presence with focus on premium, craft-grown product Company is building 1.38 million square feet of cultivation facilities in Canada, Jamaica New Acquisitions Corporation will focus on monetizing TGOD’s experience in finding worldwide opportunities Enters LOI with Denmark-based Knud Jepsen, increasing funded capacity to 195,000 kg annually Amid the rush to market cannabis products in increasingly varied ways, medical cannabis research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) is preparing to reward its shareholders and boost its bottom line by spinning off a new corporation that…

FridayAug 17, 2018 1:42 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery

Smoking-related deaths have reached six million a year worldwide Lexaria’s patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking’s hazards Second round of testing continues to indicate that patented DehydraTECH™ platform provides rapid delivery with high bioavailability As world drug industry regulations undergo revolutionary change and increasingly healthy populations find themselves challenged to meet the cares of old age, Canadian biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is forging a path that establishes it as a pioneer in the field of drug delivery platforms. Lexaria’s mission is to ensure…

ThursdayAug 16, 2018 1:47 pm

PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Medicinal Cannabis Division Targets Treatment Option for Anxiety Disorders

Anxiety is implicated in several chronic physical illnesses including heart disease, respiratory disorders and gastrointestinal conditions Scientific evidence in several studies shows that CBD exhibits anti-inflammatory and anti-anxiety properties Newly created medicinal cannabis division will focus on development of cannabinoids as preventative treatment for anxiety disorders Use of PreveCeutical’s proprietary Sol-gel nasal delivery platform for cannabinoid therapy promises ease of use, sustained release, better efficacy Preventative medicine industry represents a $3.8 trillion market Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is tackling a topic that many people hesitate to bring up – anxiety disorders, including…

MondayAug 13, 2018 12:09 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is Named for its Attention to Preventative Health Care

Private placement of $4.9 million in June 2018 Five R&D programs currently underway Preventative health care market set to reach $200 billion by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is on a mission neatly expressed in its name and in the metaphoric maxim “an ounce of prevention is worth a pound of cure.” Yet, notwithstanding that axiom, medicinal practice and health care have been viewed, for almost a millennium, mainly as “cure,” despite always being administered with a dose of “prevention.” Now, in the 21st century, that auxiliary aspect seems to be gaining the recognition it…

MondayAug 13, 2018 11:36 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study on TurboCBD Capsules Corroborates Earlier DehydraTECH Test Results

Significant bioavailability results were reported from LXRP’s randomized, double-blind European study that evaluated its proprietary TurboCBD capsules, powered by DehydraTECH Results corroborate and confirm in vitro and in vivo studies of DehydraTECH technology that measured high levels of drug delivery being achieved faster than with matching controls LXRP says that it is pleased that DehydraTECH has, to date, repeatedly proved evidence of success within human studies; technology earlier demonstrated ability to deliver nicotine Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is pleased to report significant bioavailability results from its randomized and double-blind European human clinical study of DehydraTECH™ powered TurboCBD™…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977